The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eason, D. D.
Right arrow Articles by Blanck, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eason, D. D.
Right arrow Articles by Blanck, G.
The Journal of Immunology, 2001, 166: 1041-1048.
Copyright © 2001 by The American Association of Immunologists

High Level Class II trans-Activator Induction Does Not Occur with Transient Activation of the IFN-{gamma} Signaling Pathway1

Donna D. Eason* and George Blanck2,*,{dagger}

* Department of Biochemistry and Molecular Biology, College of Medicine, and {dagger} Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612

Gene activation in early development is highly dependent on precise concentrations of trans-acting factors for the activation of different genes at differing points in the embryo. Thus, not only is the presence or absence of a particular trans-activator or repressor relevant in determining gene activation, but also the concentration of the regulatory protein must be above or below a certain threshold for proper gene regulation. Signaling pathways in somatic cells are thought to represent cascades of on/off switches, mediated most commonly by phosphorylation. Here we demonstrate a quantitative mechanism for regulating the level of a component of the IFN-{gamma} signaling pathway that in effect represents the differential sensitivities of STAT1, IFN-regulatory factor-1, and class II trans-activator (CIITA) to IFN-{gamma}. Unlike developmental gene regulation, in which specificity of gene activation is a function of regulatory protein concentrations, specificity of gene activation in the IFN-{gamma} signaling pathway is regulated by the duration of the activation of the primary IFN-{gamma}-regulatory protein, STAT1. This result most likely explains previously reported data indicating that a minimum amount of IFN-{gamma} is required for MHC class II gene activation despite the fact that the level of the IFN-{gamma}-inducible factor directly required for MHC class II induction, CIITA, directly correlates with the level of MHC class II expression. The induction of a high level of CIITA is dependent on sustained IFN-{gamma} signaling. The possible implications of this result for tumorigenesis are discussed.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
N. Chetoui, K. Sylla, J.-V. Gagnon-Houde, C. Alcaide-Loridan, D. Charron, R. Al-Daccak, and F. Aoudjit
Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis
Mol. Cancer Res., January 1, 2008; 6(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. C. Choi, R. Holtz, M. G. Petroff, N. Alfaidy, and S. P. Murphy
Dampening of IFN-{gamma}-Inducible Gene Expression in Human Choriocarcinoma Cells Is Due to Phosphatase-Mediated Inhibition of the JAK/STAT-1 Pathway
J. Immunol., February 1, 2007; 178(3): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck
Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER
J. Biol. Chem., July 9, 2004; 279(28): 28911 - 28919.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. A. Muczynski, D. M. Ekle, D. M. Coder, and S. K. Anderson
Normal Human Kidney HLA-DR-Expressing Renal Microvascular Endothelial Cells: Characterization, Isolation, and Regulation of MHC Class II Expression
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1336 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. K. Pai, D. Askew, W. H. Boom, and C. V. Harding
Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
J. Immunol., August 1, 2002; 169(3): 1326 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kumatori, D. Yang, S. Suzuki, and M. Nakamura
Cooperation of STAT-1 and IRF-1 in Interferon-gamma -induced Transcription of the gp91phox Gene
J. Biol. Chem., March 8, 2002; 277(11): 9103 - 9111.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Osborne, H. Zhang, W.-M. Yang, E. Seto, and G. Blanck
Histone Deacetylase Activity Represses Gamma Interferon-Inducible HLA-DR Gene Expression following the Establishment of a DNase I-Hypersensitive Chromatin Conformation
Mol. Cell. Biol., October 1, 2001; 21(19): 6495 - 6506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.